Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The zebrafish as a model to study polycystic liver disease.

Tietz Bogert PS, Huang BQ, Gradilone SA, Masyuk TV, Moulder GL, Ekker SC, Larusso NF.

Zebrafish. 2013 Jun;10(2):211-7. doi: 10.1089/zeb.2012.0825. Epub 2013 May 13.

2.

Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.

Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Masyuk AI, Gradilone SA, Gajdos GB, Chandok N, Bakeberg JL, Ward CJ, Ritman EL, Kiyokawa H, LaRusso NF.

Gastroenterology. 2012 Mar;142(3):622-633.e4. doi: 10.1053/j.gastro.2011.11.036. Epub 2011 Dec 7.

3.

Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases.

Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Gradilone SA, Huang B, Masyuk AI, Hogan MC, Torres VE, Larusso NF.

Hepatology. 2013 Jul;58(1):409-21. doi: 10.1002/hep.26140. Epub 2013 Mar 6.

4.

A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.

Fedeles SV, Tian X, Gallagher AR, Mitobe M, Nishio S, Lee SH, Cai Y, Geng L, Crews CM, Somlo S.

Nat Genet. 2011 Jun 19;43(7):639-47. doi: 10.1038/ng.860.

5.

[Cystic liver diseases. Genetics and cell biology].

Housset C.

Gastroenterol Clin Biol. 2005 Aug-Sep;29(8-9):861-9. Review. French.

6.

Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.

Wills ES, Cnossen WR, Veltman JA, Woestenenk R, Steehouwer M, Salomon J, Te Morsche RH, Huch M, Hehir-Kwa JY, Banning MJ, Pfundt R, Roepman R, Hoischen A, Drenth JP.

Eur J Hum Genet. 2016 Dec;24(12):1707-1714. doi: 10.1038/ejhg.2016.97. Epub 2016 Aug 24.

PMID:
27552964
7.

PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation.

Gao H, Wang Y, Wegierski T, Skouloudaki K, Pütz M, Fu X, Engel C, Boehlke C, Peng H, Kuehn EW, Kim E, Kramer-Zucker A, Walz G.

Hum Mol Genet. 2010 Jan 1;19(1):16-24. doi: 10.1093/hmg/ddp463.

PMID:
19801576
8.

Somatic second-hit mutations leads to polycystic liver diseases.

Banales JM, Munoz-Garrido P, Bujanda L.

World J Gastroenterol. 2013 Jan 7;19(1):141-3. doi: 10.3748/wjg.v19.i1.141.

9.

Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity.

Fedeles SV, So JS, Shrikhande A, Lee SH, Gallagher AR, Barkauskas CE, Somlo S, Lee AH.

J Clin Invest. 2015 May;125(5):1955-67. doi: 10.1172/JCI78863. Epub 2015 Apr 6.

10.

VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.

Amura CR, Brodsky KS, Groff R, Gattone VH, Voelkel NF, Doctor RB.

Am J Physiol Cell Physiol. 2007 Jul;293(1):C419-28. Epub 2007 May 2.

11.

Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.

Janssen MJ, Waanders E, Te Morsche RH, Xing R, Dijkman HB, Woudenberg J, Drenth JP.

Gastroenterology. 2011 Dec;141(6):2056-2063.e2. doi: 10.1053/j.gastro.2011.08.004. Epub 2011 Aug 19.

PMID:
21856269
12.

Mutation of sec63 in zebrafish causes defects in myelinated axons and liver pathology.

Monk KR, Voas MG, Franzini-Armstrong C, Hakkinen IS, Talbot WS.

Dis Model Mech. 2013 Jan;6(1):135-45. doi: 10.1242/dmm.009217. Epub 2012 Aug 3.

13.

Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.

Cnossen WR, Maurits JS, Salomon J, Te Morsche RH, Waanders E, Drenth JP.

J Clin Lab Anal. 2016 Sep;30(5):431-6. doi: 10.1002/jcla.21875. Epub 2015 Sep 13.

PMID:
26365003
14.

The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation.

Mangos S, Lam PY, Zhao A, Liu Y, Mudumana S, Vasilyev A, Liu A, Drummond IA.

Dis Model Mech. 2010 May-Jun;3(5-6):354-65. doi: 10.1242/dmm.003194. Epub 2010 Mar 24.

15.

The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.

Lager DJ, Qian Q, Bengal RJ, Ishibashi M, Torres VE.

Kidney Int. 2001 Jan;59(1):126-36.

16.

Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin.

Kim I, Ding T, Fu Y, Li C, Cui L, Li A, Lian P, Liang D, Wang DW, Guo C, Ma J, Zhao P, Coffey RJ, Zhan Q, Wu G.

J Am Soc Nephrol. 2009 Dec;20(12):2556-69. doi: 10.1681/ASN.2009030271. Epub 2009 Nov 25.

17.

Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.

Gevers TJ, Inthout J, Caroli A, Ruggenenti P, Hogan MC, Torres VE, Nevens F, Drenth JP.

Gastroenterology. 2013 Aug;145(2):357-65.e1-2. doi: 10.1053/j.gastro.2013.04.055. Epub 2013 May 7.

PMID:
23665274
18.

Insignificant effect of secretin in rodent models of polycystic kidney and liver disease.

Wang X, Ye H, Ward CJ, Chu JY, Masyuk TV, Larusso NF, Harris PC, Chow BK, Torres VE.

Am J Physiol Renal Physiol. 2012 Oct;303(7):F1089-98. doi: 10.1152/ajprenal.00242.2012. Epub 2012 Jul 18.

19.

Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.

Waanders E, te Morsche RH, de Man RA, Jansen JB, Drenth JP.

Hum Mutat. 2006 Aug;27(8):830.

PMID:
16835903
20.

Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p.

Waanders E, Croes HJ, Maass CN, te Morsche RH, van Geffen HJ, van Krieken JH, Fransen JA, Drenth JP.

Histochem Cell Biol. 2008 Mar;129(3):301-10. doi: 10.1007/s00418-008-0381-3. Epub 2008 Jan 26.

PMID:
18224332

Supplemental Content

Support Center